Oncocyte Corp Quarterly Operating Lease, Payments in USD from Q1 2019 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Oncocyte Corp quarterly/annual Operating Lease, Payments history and growth rate from Q1 2019 to Q1 2024.
  • Oncocyte Corp Operating Lease, Payments for the quarter ending March 31, 2024 was $272K, a 4.9% decline year-over-year.
  • Oncocyte Corp annual Operating Lease, Payments for 2023 was $1.05M, a 8.31% decline from 2022.
  • Oncocyte Corp annual Operating Lease, Payments for 2022 was $1.14M, a 9.69% increase from 2021.
  • Oncocyte Corp annual Operating Lease, Payments for 2021 was $1.04M, a 88.8% increase from 2020.
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $272K -$14K -4.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $286K +$9K +3.25% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $277K +$57K +25.9% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $220K +$142K +182% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $78K +$66K +550% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $12K Jan 1, 2019 Mar 31, 2019 10-Q 2019-05-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.